Astellas Pharma Inc.
アステラス製薬株式会社
Valuation
Fundamental ratios for the latest reported period.
Ticker: 4503
FY2025 · 2026-03-31
| Gross margin | 80.9% |
| Operating margin | 17.9% |
| Net margin | 13.6% |
| Return on equity | 15.9% |
| Return on assets | 8.2% |
| Revenue growth (YoY) | 11.9% |
| EPS (basic) | ¥162.77 |
| EPS growth (YoY) | 474.1% |
| Current ratio | — |
| Equity ratio | 51.3% |
| Book value / share | ¥892.92 |
| Free cash flow | 502,465 M |